U.S. markets open in 8 hours 35 minutes

XPhyto Therapeutics Corp. (XPHYF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3570+0.0058 (+1.65%)
At close: 12:49PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3512
BidN/A x N/A
AskN/A x N/A
Day's Range0.3570 - 0.3570
52 Week Range0.2736 - 1.5993
Avg. Volume1,703
Market Cap28.834M
Beta (5Y Monthly)-0.04
PE Ratio (TTM)N/A
EPS (TTM)-0.1790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for XPHYF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: New Oriental Education & Technology Group Inc.EDU, founded in 1993, is the largest well-established one-stop shopping private educational services provider in China. EDU has had over 52.8 million student enrollments, including about 8.4 million enrollments in fiscal 2019. As of third-quarter fiscal 2020, EDU had a network of 1,416 learning centers, including 99 schools, 12 bookstores and access to a national network of online and offline bookstores through 160 third-party distributors and over 38,400 highly qualified teachers in 86 cities. EDU offers a diversified portfolio of educational programs, services and products to students in different age groups, including K-12 after-school tutoring for major academic subjects, overseas and domestic test preparations, nonacademic languages and services in vocational training, and so on.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more

    XPhyto Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

    XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY) is pleased to announce that the Company has closed the first tranche of its previously announced non-brokered private placement in the amount of 2,810,000 units of the Company (the "Units") at a price of $0.36 per Unit for gross proceeds of $1,011,600 (the "Tranche").


    XPhyto Therapeutics Announces Offering of Units of the Company

    XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY) is pleased to announce a non-brokered private placement for gross proceeds of a maximum of CAD$3,600,000 (the "Offering") of units (the "Units") at an issue price of $0.36 per Unit. Each Unit will consist of one common share in the capital of the Company (a "Common Share") and one half of one Common Share purchase Warrant (each whole warrant, a "Warrant").


    XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease

    XPhyto Therapeutics Corp. (CSE:XPHY),(OTCQB:XPHYF), (FSE:4XT) ("XPhyto" or the "Company") is pleased to report a significant potential market opportunity for its oral dissolvable ("ODF") biosensor screening tests for oral inflammation. Certain buprenorphine medicines prescribed to treat opioid use disorder ("OUD") and pain have been recently associated with numerous serious oral health problems requiring medical intervention.